Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
 Guidance System - EconoTimes)
ORLANDO, Fla., April 20, 2016 -- On April 4, Dr. Payam Moazzaz performed the 700th Mazor Robotics Renaissance® Spine Surgery case at Tri-City Medical Center. The Renaissance system uses mechanical guidance to help surgeons place pedicle screws and implants with unparalleled accuracy to correct conditions such as scoliosis and degenerative disc disease.
Located in Oceanside, CA, Tri-City Medical Center is a Gold Seal-approved, full-service, acute-care hospital with advanced clinical institutes for orthopaedic and cardiovascular care. Tri-City Medical Center has 397 beds and over 700 physicians practicing in 60 specialties. Tri-City Medical Center purchased its first Renaissance system in February 2012 and a second system in December of the same year.
"The Mazor Robotics system allows us to perform even the most difficult cases with confidence," said Dr. Moazzaz. "With Renaissance, we are able to provide our patients with the best care and that is why we continue to use the technology for so many of our cases."
"Being one of the first hospitals in the country to use Renaissance technology, the surgeons at TCMC are true pioneers in their field," said Mazor Robotics Inc. CEO Christopher Prentice. "We congratulate their team on reaching this milestone and thank everyone at TCMC for truly believing in the technology and helping us to change the landscape of spine surgery."
Since coming to the market in 2011, over 15,000 procedures have been performed with the Renaissance system at over 100 hospitals worldwide. Numerous peer-reviewed publications and presentations at leading scientific conferences have validated the accuracy, usability, and clinical advantages of spine surgery with Mazor Robotics technology. For more information, please visit www.MazorRobotics.com.
About Mazor
|
|||||
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary robotic-based technology and products aimed at redefining the gold standard of quality care. Mazor Robotics Renaissance® Guidance System enables surgeons to conduct spine and brain procedures in a more accurate and secure manner.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=39907
CONTACT: Stephani Shipman
Marketing Communications Manager
(407) 591-3461
[email protected]
